EAM Global Investors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-63,143
| Closed | -$2.27M | – | 90 |
|
|
2023
Q1 | $2.27M | Sell |
63,143
-8,911
| -12% | -$321K | 0.64% | 80 |
|
|
2022
Q4 | $3.21M | Buy |
+72,054
| New | +$3.21M | 0.83% | 27 |
|
|
2021
Q4 | – | Sell |
-96,528
| Closed | -$5.21M | – | 204 |
|
|
2021
Q3 | $5.21M | Buy |
96,528
+25,290
| +36% | +$1.37M | 1.23% | 6 |
|
|
2021
Q2 | $2.38M | Buy |
+71,238
| New | +$2.38M | 0.66% | 63 |
|
|
2021
Q1 | – | Sell |
-69,557
| Closed | -$1.22M | – | 149 |
|
|
2020
Q4 | $1.22M | Sell |
69,557
-29,193
| -30% | -$512K | 0.33% | 126 |
|
|
2020
Q3 | $1.46M | Buy |
+98,750
| New | +$1.46M | 0.54% | 95 |
|